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ABSTRACT
Introduction: The purpose of this report is to evaluate
our experience with transvaginal application of a laparo-
scopic bipolar cutting forceps to assist vaginal hysterec-
tomy in extremely obese women with endometrial cancer
in whom obesity precluded LAVH/BSO and lymphade-
nectomy and vaginal obesity limited visualization and
exposure.
Materials and Methods: We performed a retrospective
review and identified 6 consecutive cases. No cases were
excluded. A laparoscopic 33-cm Plasma Kinctic (PK) cut-
ting forceps with a 5-mm diameter was applied transvagi-
nally to coagulate and cut the uterosacral and cardinal
ligaments, uterine vasculature, and ovarian ligaments. The
uterus was delivered vaginally. Staging lymphadenectomy
was not performed.
Results: Median age was 51 years, median weight was
405 lbs, and median BMI was 66 kg/m
2. Five of 6 cases
were successfully performed vaginally (83%). Median op-
erative time was 1hour 10 minutes, median blood loss was
500 mL, and pain was only discomforting. All patients
were discharged the day after surgery. There were no
complications. At median follow-up of 1 year, all patients
were alive with no evidence of disease.
Conclusion: It is our opinion that the transvaginal appli-
cation of a laparoscopic bipolar cutting forceps can suc-
cessfully assist vaginal hysterectomy in extremely obese
endometrial cancer patients who cannot tolerate LAVH/
BSO and lymphadenectomy and vaginal obesity limits
visualization and exposure.
Key Words: Laparoscopic bipolar cutting forceps; Hys-
terectomy in the obese.
INTRODUCTION
Advanced laparoscopic procedures are increasingly being
utilized as an alternative to laparotomy in gynecologic
surgery.1,2 A metaanalysis of 27 prospective randomized
trials has proven the benefits of laparoscopic-assisted vag-
inal hysterectomy (LAVH) compared with abdominal hys-
terectomy (AH): decreased pain, decreased surgical-site
infections (decreased relative risk 80%), decreased hospi-
tal stay (2 days less), quicker return to activity (2 weeks
sooner), and fewer postoperative adhesions (decreased
60%).3 In a cost-effectiveness analysis of LAVH versus AH,
there was no significant increased cost with LAVH.4
Advanced laparoscopic procedures are also increasingly
being utilized as an alternative for laparotomy in gyneco-
logic oncology surgery. LAVH/BSO with lymphadenec-
tomy has become a standard treatment for endometrial
cancer.5–8 In some extremely obese patients, LAVH/BSO
and lymphadenectomy cannot be safely performed be-
cause of potential anesthetic complications secondary to a
decreased tolerance to the Trendelenburg position, and
vaginal obesity limits visualization and exposure.
We have recently published a case report9 on the trans-
vaginal application of a laparoscopic-pulsed bipolar-
energy instrument used in completing a difficult vaginal
hysterectomy. Laparoscopic instruments are inherently
thin and long, which is desirable when a difficult vaginal
hysterectomy is being performed. Since the report of this
case, we have used the laparoscopic cutting forceps trans-
vaginally to assist vaginal hysterectomy in extremely
obese women with endometrial cancer in whom obesity
precluded LAVH/BSO and lymphadenectomy and vaginal
obesity limited visualization and exposure.
The purpose of this report is to evaluate our experience
with the transvaginal application of a laparoscopic cutting
forceps for vaginal hysterectomy in extremely obese
women with endometrial cancer.
MATERIALS AND METHODS
We performed a retrospective review of the senior au-
thor’s surgical case log and identified 6 consecutive cases
in which the laparoscopic bipolar cutting forceps was
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SCIENTIFIC PAPERused transvaginally to assist vaginal hysterectomies in ex-
tremely obese women with endometrial cancer. No cases
were excluded. These 6 cases occurred over a 2-year
period and included all patients in whom obesity pre-
cluded LAVH/BSO and lymphadenectomy, and vaginal
obesity limited visualization and exposure. Following in-
tubation, Trendelenburg positioning was attempted, and
the anesthesiologist determined that an adequate Tren-
delenburg position could not be safely maintained. IRB
approval was obtained.
All patients received a preoperative bowel prep with 45
mL of fleets phosphosoda orally, a single dose of preop-
erative prophylactic antibiotics, and external pneumatic
cuffs.
All procedures were performed with the patient under
general endotracheal anesthesia. An orogastric tube was
inserted and removed at the end of surgery. The patient
was positioned in the dorsolithotomy position with legs
in stirrups. The cervicovaginal junction was opened
with monopolar electrosurgery. Blunt dissection of the
anterior and posterior cul-de-sacs was performed. With
the bladder and rectum retracted, a laparoscopic 33-cm
long PlasmaKinctic (PK) cutting forceps 5-mm in diam-
eter (Gyrus ACMI, Southborough, MA) was applied to
the uterosacral ligament, coagulated, and cut (Figure 1).
After several applications on the uterosacral and cardinal
ligaments, there was adequate dissent to enter the anterior
and posterior cul-de-sac. The PK cutting forceps was used
to transect the uterine vasculature, fallopian tubes, and
ovarian ligaments, and the uterus was delivered vaginally.
The ovaries and fallopian tubes were then grasped, and
the infundibulopelvic ligaments were also coagulated
with the PK cutting forceps. Uterosacral vaginal fixation
stitches were placed. Reperitonealization was performed
when possible. The vagina was closed with interrupted O
polyglycolic acid sutures and packed. Staging lymphade-
nectomy was not performed.
All patients were placed on a general diet and given
bowel simulation with 30 mL of milk of magnesia and
discharged the day following surgery. Patients were fol-
lowed up at 1 week, 4 weeks, and every 3 months for 1
year.
RESULTS
Median age was 51 years (range, 45 to 52), median weight
was 405 lbs (range, 370 to 452), and median BMI was 66
kg/m
2 (range, 55-77) (Table 1). All patients were Cauca-
sian and had multiple medical comorbidities. Fifty percent
of patients had previous pelvic surgery including cesarean
delivery.
Five of 6 cases were successfully performed vaginally
(83%). Median operative time was 1 hour 10 minutes
(range, 1 hr 9 min to 1 hr 35 min). Median blood loss was
500 mL (range, 400 to 700 mL). There were no intraoper-
ative complications. Median Visual Analog Scoring (VAS)
system10 on the day following surgery was 4-discomfort-
ing (range, 3 to 4). All patients were discharged on the day
after surgery. No patient developed a postoperative com-
plication.
Uterine stage was as follows: 1 patient -1AG1, 3 patients
-1BG1, 1 patient -1BG2, and 1patient -1CG1. No patient
received adjuvant postoperative treatment. At median fol-
low-up of one year, all patients were alive with no evi-
dence of disease.
The single unsuccessful case was due to a 10-cm anterior
vaginal leiomyoma that precluded entry into the anterior
cul-de-sac. Surgery was completed through a Maylard
laparotomy. Operative time was 3 hours and 45 minutes,
blood loss was 800 mL, VAS was 6-distressing, and hos-
pital stay was 2 days.
DISCUSSION
We have previously reported on the advantages of
LAVH1,2,4 and surgical staging of endometrial can-
cer,11–15 and thus believe that the optimum surgical
treatment for women with endometrial cancer is LAVH/
BSO and lymphadenectomy. In some extremely obese
patients, LAVH/BSO and lymphadenectomy cannot be
safely performed because of the increased risk of anes-
thetic complications. The Trendelenburg position in
extremely obese patients undergoing laparoscopy can
result in excessive peak airway pressure and pulmonary
barotrauma.16
Figure 1. Vaginal application of a laparoscopic PlasmaKinetic
(PK) cutting forceps to resect uterosacral ligaments.
Transvaginal Application of a Laparoscopic Bipolar Cutting Forceps to Assist Vaginal Hysterectomy in Extremely Obese Endometrial
Cancer Patients, Fanning J et al.
JSLS (2010)14:183–186 184The Trendelenburg position must then be discontinued,
resulting in inadequate pelvic exposure. Several recent
studies have evaluated laparoscopic surgery for obese en-
dometrial cancer patients.5–8 However, the median BMI in
these studies (30,5 35,6 35,7 418 kg/m
2) is approximately
one-half of our BMI of 66 kg/m
2.
In some extremely obese patients, vaginal hysterectomy is
difficult because vaginal obesity causes sidewall collapse
that limits visualization and exposure, which precludes
the use of the conventional clamp-suture technique. Use
of the long, thin (5 mm) PK coagulator allows adequate
visualization of the uterine pedicles. The PK system uses
pulsed bipolar energy for coagulation, measuring, and
remeasuring the tissue impedance or resistance during
coagulation to assure complete coagulation and hemo-
stasis without excessive cautery effect or undesired
spread to adjacent tissues or structures. Although the
use of vaginal electrosurgical bipolar technology has
been reported,17 these vaginal instruments are too
bulky and short for extremely obese endometrial cancer
patients.
Extremely obese endometrial cancer patients could be
treated via laparotomy. However, operative and postop-
erative complications can be severe.8 Primary teletherapy
could also be used, but complications can be significant,
and the cure rate is decreased.18
CONCLUSION
We report on the successful use of transvaginal applica-
tion of a laparoscopic bipolar cutting forceps to assist
vaginal hysterectomy in extremely obese endometrial can-
cer patients. Five of 6 cases were successfully performed
vaginally (83%). Median operative time was 1 hour 10
minutes, median blood loss was 500 mL, pain was only
discomforting, all patients were discharged the day after
surgery, there were no postoperative complications, and
all patients are alive and free of disease. It is our opinion
that transvaginal application of a laparoscopic bipolar
cutting forceps can successfully assist vaginal hysterec-
tomy in extremely obese endometrial cancer patients in
whom LAVH/BSO and lymphadenectomy cannot be
safely performed, and vaginal obesity limits visualization
and exposure. It must be emphasized that this is a chal-
lenging surgical procedure. All surgeries were performed
by a senior gynecologic oncologist with extensive expe-
rience in radical laparoscopic and vaginal surgery. Also, 2
gynecologic residents assisted in all cases. If these surger-
ies were elective, rather than oncologic, we would recom-
mend weight loss prior to surgery.
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